Business & Regulation

Business & Regulation Digital Technologies

08/03/2022 | Maryam Mahdi | 4 min read

Data management can be difficult but the right systems can help pharma manage the vast volumes of data it amasses.

Business & Regulation Business Practice

08/01/2022 | Kariem Abdellatif | 3 min read

What are the best locations for a pharma business to base entities when it comes to operating costs?

Business & Regulation Digital Technologies

08/01/2022 | Maryam Mahdi | 4 min read

What difference will decentralized trials make to the future of clinical trials?

Business & Regulation Profession

07/29/2022 | Angus Stewart | 9 min read

What happened at ISCT 2022’s return to in-person conferencing – and what can a new film release do for advanced therapy?

Business & Regulation COVID-19

07/28/2022 | Stephanie Vine | 3 min read

Why, oh why, is there so much nonsense and misinformation about COVID-19 vaccines?

Business & Regulation Profession

07/25/2022 | Stephanie Vine | 4 min read

Members of The Medicine Maker 2022 Power List reveal fascinating facts about themselves.

Business & Regulation Business Practice

07/22/2022 | Maryam Mahdi | 2 min read

How will pharma companies navigate America’s new abortion laws?

Business & Regulation Trends & Forecasts

07/21/2022 | Angus Stewart | 9 min read

The International Society for Cell & Gene Therapy convened in person for the first time in two years. We spoke to an attendee for an insight

Business & Regulation Business Practice

07/20/2022 | Angus Stewart | 7 min read

In our third C+G Champions installment, we ask industry leaders in the cell and gene field about accessibility for the many

Business & Regulation Standards & Regulation

07/12/2022 | Shabbir Imber Safdar | 8 min read

The US drug supply chain is not immune to counterfeits – but there’s a law for that. Here’s how it has been used so far.